Cipla Ltd reported a 32.25% rise in consolidated profit to Rs 1,068.41 crore in Q3 FY24, driven by strong revenue growth. Read more.
Photograph: Danish Siddiqui/Reuters
New Delhi, Jan 22 (PTI) Pharmaceuticals firm Cipla Ltd on Monday reported a 32.25 per cent rise in consolidated profit to Rs 1,068.41 crore in the third quarter ended December 2023.
The company had posted a consolidated profit of Rs 807.83 crore in the year-ago period, Cipla Ltd said in a regulatory filing.
Consolidated revenue from operation in the quarter under review was Rs 6,603.81 crore, up 13.66 per cent. It was Rs 5,810.09 crore in the corresponding period a year ago.
In the December quarter, its total expenses were 8.78 per cent higher at Rs 5,119.81 crore as against Rs 4,706.47 crore in the October-December quarter last fiscal, the company said.
Total income of Cipla in the third quarter stood at Rs 6.788.44 crore, up 14.58 per cent.
During the quarter, its revenue from pharmaceuticals was Rs 6,365.06 crore, and from new ventures was Rs 280.51 crore.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback